Other Titles

Considerations in genomics

Abstract

Pharmacogenomic testing offer a unique opportunity to personalize care for individual patients. Although testing is widely available, uptake in the clinical setting is slow. This study explores why pharmacogenomic testing is not widely used among nurse anesthetists in clinical practice.

Authors

J. Dru Riddle

Author Details

J. Dru Riddle, PhD, CRNA, School of Nurse Anesthesia, Texas Christian University, Fort Worth, Texas, USA

Sigma Membership

Gamma

Lead Author Affiliation

Texas Christian University, Fort Worth, Texas, USA

Type

Presentation

Format Type

Text-based Document

Study Design/Type

N/A

Research Approach

Mixed/Multi Method Research

Keywords:

Clinical Utility, Mixed-Method, Pharmacogenomic Testing

Conference Name

29th International Nursing Research Congress

Conference Host

Sigma Theta Tau International

Conference Location

Melbourne, Australia

Conference Year

2018

Rights Holder

All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.

All permission requests should be directed accordingly and not to the Sigma Repository.

All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.

Acquisition

Proxy-submission

Share

COinS
 

Clinical utility of pharmacogenomic testing among nurse anesthetists: A mixed-method study

Melbourne, Australia

Pharmacogenomic testing offer a unique opportunity to personalize care for individual patients. Although testing is widely available, uptake in the clinical setting is slow. This study explores why pharmacogenomic testing is not widely used among nurse anesthetists in clinical practice.